JOURNAL ARTICLE

New data on early management of patients with ST-elevation myocardial infarction

David P Faxon
Current Cardiology Reports 2008, 10 (4): 291-8
18611363
The advances in the early treatment of ST-segment elevation acute myocardial infarction have resulted in a significant reduction in mortality. Early pharmacologic therapy with antiplatelet and antithrombotic therapy coupled with rapid and complete mechanical or pharmacologic reperfusion has been shown to reduce infarct size, improve left ventricular function, and reduce morbidity and mortality. Primary angioplasty, if done by an experienced team in a timely manner, has been found to be superior to fibrinolytic therapy and superior to facilitated angioplasty. The American College of Cardiology/American Heart Association guidelines recommend the goal of a door-to-balloon time of less than 90 minutes. National efforts to reduce delays and to improve access to timely therapy will significantly reduce mortality even further.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
18611363
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"